¼¼°èÀÇ ³¶Æ÷¼º ¼¶À¯Áõ¿ë ±âµµ È®º¸ ±â±â ½ÃÀå º¸°í¼­(2025³â)
Airway Clearance Devices For Cystic Fibrosis Global Market Report 2025
»óǰÄÚµå : 1716912
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,242,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,023,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,803,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

³¶Æ÷¼º ¼¶À¯Áõ¿ë ±âµµ È®º¸ ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. 2029³â¿¡´Â CAGR 6.0%·Î 34¾ï 8,000¸¸ ´Þ·¯·Î ¼ºÀåÇÕ´Ï´Ù. ¿¹Ãø ±â°£ Áß ¸¸¼º È£Èí±â Áúȯ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, º´¿ë ¿ä¹ý °³¹ß, ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, °³ÀÎÈ­µÈ ÀÇ·á ¼­ºñ½º äÅà µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ ±â°£ Áß ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, °³ÀÎ ¸ÂÃãÇü Ä¡·á, ¿þ¾î·¯ºí ±â±â, º´¿ë¿ä¹ý, ÀΰøÁö´ÉÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

Æó ÁúȯÀÇ ¹ß»ý·ü Áõ°¡´Â °¡±î¿î ¹Ì·¡¿¡ ³¶Æ÷¼º ¼¶À¯Áõ¿ë ±âµµ È®º¸ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Æó ÁúȯÀº Á¡¾× °ú´Ù »ý¼º ¹× Æó ±â´É ÀúÇϸ¦ ÃÊ·¡ÇÏ´Â ÁúȯÀ¸·Î, ±âµµ¸¦ ±ú²ýÇÏ°Ô Çϰí È£Èí±â °Ç°­À» ÁõÁø½ÃŰ´Â È¿°úÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æó Áúȯ Áõ°¡´Â ´ë±â ¿À¿°, Èí¿¬, ´ã¹è ¼Òºñ Áõ°¡ µî ´Ù¾çÇÑ »óÈ£ ¿¬°üµÈ ¿äÀο¡ ±âÀÎÇϸç, ÀÌ´Â ¸ðµÎ È£Èí±â Áúȯ ¹× Àå±âÀûÀÎ Æó ÁúȯÀÇ ½É°¢ÇÑ ¿øÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. °íÁÖÆÄ È亮 Áøµ¿(HFCWO) Á¶³¢, È£±â ¾ç¾Ð(PEP) ±â±â, Áøµ¿½Ä PEP ±â±â¿Í °°Àº±âµµ Ŭ¸®¾î·±½º ±â±â´Â ±âµµÀÇ µÎ²¨¿î Á¡¾×À» ºÐÇØÇϰí Á¦°ÅÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»Çϸç, ƯÈ÷ ¸¸¼º Æó °¨¿°°ú È£Èí Àå¾Ö¸¦ À¯¹ßÇÏ´Â µÎ²®°í ²öÀû ²öÀûÇÑ Á¡¾×À¸·Î °íÅë¹Þ´Â ³¶Æ÷¼º ¼¶À¯Áõ ȯÀÚ¿¡°Ô ƯÈ÷ À¯ÀÍÇÕ´Ï´Ù. ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 3¿ù ¹Ì±¹ Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ(CDC)´Â °áÇ٠ȯÀÚ ¼ö°¡ 2022³â 8,320¸í¿¡¼­ 2023³â 9,615¸íÀ¸·Î 1,295¸í Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌó·³ ÆóÁúȯÀÇ À¯º´·ü Áõ°¡´Â ³¶Æ÷¼º ¼¶À¯Áõ¿¡¼­ ±âµµ È®º¸ ±â±â ½ÃÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

³¶Æ÷¼º ¼¶À¯Áõ¿ë ±âµµ È®º¸ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº Á¡¾× û¼Ò È¿°ú¸¦ ³ôÀ̰í, ȯÀÚÀÇ Æí¾ÈÇÔÀ» °³¼±Çϰí, Ä¡·á ½Ã°£À» ´ÜÃàÇϰí, ºñħ½ÀÀû ÀçÅà ġ·á ¿É¼ÇÀ» Á¦°øÇϱâ À§ÇØ °íÁÖÆÄ È亮 Áøµ¿ ±â¼ú°ú °°Àº ±â¼ú Çõ½Å¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ³¶Æ÷¼º ¼¶À¯Áõ ȯÀÚÀÇ ÀÓ»ó °á°ú°¡ °³¼±µÇ°í »îÀÇ ÁúÀÌ Çâ»óµË´Ï´Ù. °íÁÖÆÄ È亮 Áøµ¿ ±â¼úÀº ºü¸¥ °ø±â ÆÞ½º¸¦ »ç¿ëÇÏ¿© È亮¿¡ Áøµ¿À» ÁÖ¾î Á¡¾×À» Ç®°í µ¿¿øÇÏ¿© Æó¿¡¼­ Á¡¾×À» ½±°Ô Á¦°ÅÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 9¿ù ¹Ì±¹ ÇコÄÉ¾î ±â¾÷ ¹Ú½ºÅÍ ÀÎÅͳ»¼Å³Î(Baxter International)Àº ºÏ¹Ì ³¶Æ÷¼º ¼¶À¯Áõ ÇÐȸ¿¡¼­ Â÷¼¼´ë ±âµµ È®º¸ ½Ã½ºÅÛÀÎ Vest Advanced Pulmonary Experience(APX) ½Ã½ºÅÛÀ» ¹ßÇ¥Çß½À´Ï´Ù. ½Ã½ºÅÛÀº ÀÌÀü ¸ðµ¨ÀÇ ½Å·ÚÇÒ ¼ö ÀÖ´Â °ø±â È帧 ±â¼úÀ» °è½ÂÇϸ鼭 ÀÓ»óÀÇ¿Í È¯ÀÚ ¸ðµÎÀÇ Çǵå¹éÀ» ¹ÙÅÁÀ¸·Î Æí¾ÈÇÔ°ú ȯÀÚ Áß½ÉÀÇ ±â´ÉÀ» °­È­ÇÑ ½Ã½ºÅÛÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¸¸¼º ÆóÁúȯ ¹× ºÐºñ¹° Àú·ù°¡ ÀÖ´Â ¼ºÀÎ ¹× ¼Ò¾Æ ȯÀÚÀÇ ÀÏ»óÀûÀÎ Ä¡·á¸¦ Áö¿øÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½ºÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Airway clearance devices for cystic fibrosis are medical instruments designed to assist in clearing mucus from the lungs, thereby improving respiratory function and reducing the likelihood of lung infections. These devices are primarily used to manage respiratory symptoms, boost lung function, and enhance the quality of life for individuals with cystic fibrosis or other chronic respiratory conditions.

The key types of airway clearance devices for cystic fibrosis include vest systems, intrapulmonary percussive ventilators (IPV), positive expiratory pressure (PEP) devices, high-frequency chest wall oscillation (HFCWO) devices, and other related devices. Vest systems are wearable devices that use rapid air pulses to help clear mucus from the lungs. These devices are used by both adult and pediatric patients with cystic fibrosis. They are commonly found in hospitals, clinics, home healthcare settings, and other healthcare environments.

The airway clearance devices for cystic fibrosis market research report is one of a series of new reports from The Business Research Company that provides airway clearance devices for cystic fibrosis market statistics, including airway clearance devices for cystic fibrosis industry global market size, regional shares, competitors with a airway clearance devices for cystic fibrosis market share, detailed airway clearance devices for cystic fibrosis market segments, market trends and opportunities, and any further data you may need to thrive in the airway clearance devices for cystic fibrosis industry. This airway clearance devices for cystic fibrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The airway clearance devices for cystic fibrosis market size has grown strongly in recent years. It will grow from $2.59 billion in 2024 to $2.76 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to factors such as the increasing prevalence of cystic fibrosis, the expansion of supportive government healthcare policies, improvements in healthcare infrastructure, rising healthcare insurance coverage, and a growing incidence of respiratory diseases.

The airway clearance devices for cystic fibrosis market size is expected to see strong growth in the next few years. It will grow to $3.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. For the forecast period, growth is expected due to factors such as the increasing incidence of chronic respiratory diseases, the growing geriatric population, the development of combination therapies, rising demand for non-invasive treatments, and the adoption of personalized healthcare. Key trends expected during this period include technological advancements, personalized therapy, wearable devices, combined therapies, and the integration of artificial intelligence.

The growing incidence of lung disorders is anticipated to drive the expansion of the airway clearance devices market for cystic fibrosis in the near future. Lung disorders are conditions that result in the excessive production of mucus and impaired lung function, leading to an increasing demand for effective solutions to clear airways and enhance respiratory health. This rise in lung disorders can be attributed to various interconnected factors, including increased air pollution, smoking, and tobacco consumption, all of which significantly contribute to respiratory diseases and long-term lung damage. Airway clearance devices such as high-frequency chest wall oscillation (HFCWO) vests, positive expiratory pressure (PEP) devices, and oscillatory PEP devices play a crucial role in breaking up and clearing thick mucus from the airways, which is especially beneficial for cystic fibrosis patients who suffer from thick and sticky mucus that causes chronic lung infections and breathing problems. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported a rise in tuberculosis cases, from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Thus, the growing prevalence of lung disorders is expected to drive the market for airway clearance devices in cystic fibrosis.

Leading companies in the airway clearance devices market for cystic fibrosis are focusing on technological innovations, such as high-frequency chest wall oscillation technology, to enhance mucus clearance effectiveness, improve patient comfort, shorten treatment time, and offer non-invasive, at-home treatment options. This results in improved clinical outcomes and a better quality of life for cystic fibrosis patients. High-frequency chest wall oscillation technology uses rapid air pulses to create vibrations on the chest wall, which helps loosen and mobilize mucus, making it easier to remove from the lungs. For instance, in September 2024, Baxter International Inc., a US-based healthcare company, introduced its next-generation airway clearance system, the Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. The Vest APX System retains the reliable airflow technology from its predecessor while incorporating enhanced comfort and patient-centric features based on feedback from both clinicians and patients. This system is designed to assist with daily therapy for both adults and children with chronic lung conditions and retained secretions.

In September 2023, Inogen Inc., a US-based medical technology company, acquired Physio-Assist SAS for an undisclosed amount. Through this acquisition, Inogen intends to expand its respiratory care portfolio and address the growing and underserved airway clearance market, particularly with the Simeox device for bronchiectasis and other chronic respiratory conditions. Physio-Assist SAS, based in France, specializes in airway clearance and mucus management devices.

Major players in the airway clearance devices for cystic fibrosis market are Koninklijke Philips N.V., Baxter International Inc., ICU Medical Inc., Vyaire Medical Inc., Tactile Systems Technology Inc., RespirTech, Mercury Medical Inc., Electromed Inc., Vitality Medical Inc., Monaghan Medical Corporation, Pulmodyne Inc., PARI GmbH, Flexicare Limited, D.R. Burton Healthcare Limited, Intersurgical Ltd., Clement Clarke International Ltd., Thayer Medical Inc., AirPhysio, VORTRAN Medical Technology Inc., Med Systems Inc., Wave Healthcare

North America was the largest region in the airway clearance devices for cystic fibrosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in airway clearance devices for cystic fibrosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the airway clearance devices for cystic fibrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The airway clearance devices for cystic fibrosis market consists of sales of incentive spirometers, manual chest physiotherapy (CPT) devices and nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Airway Clearance Devices For Cystic Fibrosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on airway clearance devices for cystic fibrosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for airway clearance devices for cystic fibrosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The airway clearance devices for cystic fibrosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Airway Clearance Devices For Cystic Fibrosis Market Characteristics

3. Airway Clearance Devices For Cystic Fibrosis Market Trends And Strategies

4. Airway Clearance Devices For Cystic Fibrosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Airway Clearance Devices For Cystic Fibrosis Growth Analysis And Strategic Analysis Framework

6. Airway Clearance Devices For Cystic Fibrosis Market Segmentation

7. Airway Clearance Devices For Cystic Fibrosis Market Regional And Country Analysis

8. Asia-Pacific Airway Clearance Devices For Cystic Fibrosis Market

9. China Airway Clearance Devices For Cystic Fibrosis Market

10. India Airway Clearance Devices For Cystic Fibrosis Market

11. Japan Airway Clearance Devices For Cystic Fibrosis Market

12. Australia Airway Clearance Devices For Cystic Fibrosis Market

13. Indonesia Airway Clearance Devices For Cystic Fibrosis Market

14. South Korea Airway Clearance Devices For Cystic Fibrosis Market

15. Western Europe Airway Clearance Devices For Cystic Fibrosis Market

16. UK Airway Clearance Devices For Cystic Fibrosis Market

17. Germany Airway Clearance Devices For Cystic Fibrosis Market

18. France Airway Clearance Devices For Cystic Fibrosis Market

19. Italy Airway Clearance Devices For Cystic Fibrosis Market

20. Spain Airway Clearance Devices For Cystic Fibrosis Market

21. Eastern Europe Airway Clearance Devices For Cystic Fibrosis Market

22. Russia Airway Clearance Devices For Cystic Fibrosis Market

23. North America Airway Clearance Devices For Cystic Fibrosis Market

24. USA Airway Clearance Devices For Cystic Fibrosis Market

25. Canada Airway Clearance Devices For Cystic Fibrosis Market

26. South America Airway Clearance Devices For Cystic Fibrosis Market

27. Brazil Airway Clearance Devices For Cystic Fibrosis Market

28. Middle East Airway Clearance Devices For Cystic Fibrosis Market

29. Africa Airway Clearance Devices For Cystic Fibrosis Market

30. Airway Clearance Devices For Cystic Fibrosis Market Competitive Landscape And Company Profiles

31. Airway Clearance Devices For Cystic Fibrosis Market Other Major And Innovative Companies

32. Global Airway Clearance Devices For Cystic Fibrosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Airway Clearance Devices For Cystic Fibrosis Market

34. Recent Developments In The Airway Clearance Devices For Cystic Fibrosis Market

35. Airway Clearance Devices For Cystic Fibrosis Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â